You have a good point there. To be honest with you, I don't like to bet on Phase 3 FDA approval. Crofelemer has already been approved by the FDA, and besides, the stock is way undervalued, so I decided to invest heavily. Across all drugs and vaccines, the overall probability of success for reaching approval is approximately 13.8%. Proven proof linked below: Right now, I'm playing with house money, so my risk is virtually nothing. However, I think the chance of getting approval here is 65%. That is well worth it for me to keep my money here until she shows me her ace card. https://www.acsh.org/news/2020/06/11/clinical-trial-success-rates-phase-and-therapeutic-area-14845
Market Data 
Markets 
AI
